Boaz Nachmias
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study.
Journal: Leukemia & lymphoma
Published: July 29, 2026
Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.
Journal: Leukemia research
Published: June 07, 2026
Proteostasis meets signaling: UBE2G1 in hematopoietic stem cell aging.
Journal: Haematologica
Published: February 18, 2026
MRD conversion during oral azacitidine maintenance correlates with outcomes in predominantly favorable-risk AML.
Journal: Annals of hematology
Published: January 29, 2026
MRD conversion during oral azacitidine maintenance correlates with outcomes in predominantly favorable-risk AML.
Journal: Annals of hematology
Published: January 29, 2026
First case report of talquetamab use in AL amyloidosis.
Journal: Leukemia & lymphoma
Published: October 16, 2025
Gatekeepers of mitochondrial metabolism: the emerging role of the SLC25 family in leukemia.
Journal: Haematologica
Published: September 10, 2025
Beating the STATs: targeting the metabolome in acute myeloid leukemia.
Journal: Haematologica
Published: August 11, 2025
Measurable residual disease-guided therapy in acute myeloid leukaemia: Practical insights.
Journal: British journal of haematology
Published: May 27, 2025
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective study.
Journal: Annals of hematology
Published: February 25, 2025
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin.
Journal: Frontiers in immunology
Published: November 11, 2024
Last Updated: 09/26/2026